Focused on neurotrophic factors and their regenerative capabilities, giving rise to its present name; the company has since expanded operations int...
Senior Manager Global Patient Safety - QPPV Operations
필수 스킬
Excel
About Regeneron
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988.
전체 조회수
0
전체 지원 클릭
0
전체 Mock Apply
0
전체 스크랩
0
비슷한 채용공고
Material Lab Technician, Semi
Tesla · Sparks, Nevada
Engineering / Lab Technician, Passive Safety Testing (m/f/d), Berlin
Tesla · Kreisfreie Stadt Berlin, Be
Notfallsanitäter/Paramedic (m/w/d) - Gigafactory Berlin-Brandenburg
Tesla · Grünheide (mark), Brandenburg
Service Assistant
Tesla · Lisle, Illinois
Lack-Laborant - Chemie / Paint Lab Technician- Chemistry (m/w/d) - Gigafactory Berlin - Brandenburg
Tesla · Grünheide (mark), Brandenburg
Regeneron 소개
Regeneron
PublicRegeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988.
10,001+
직원 수
Westchester County
본사 위치
$76B
기업 가치
리뷰
10개 리뷰
3.1
10개 리뷰
워라밸
2.8
보상
3.2
문화
2.9
커리어
3.4
경영진
3.1
65%
지인 추천률
장점
Great science and people
Good learning environment
Management cares about mission
단점
Bullying and blame culture
Understaffing and burnout
Conformity pressure
연봉 정보
802개 데이터
Junior/L3
Junior/L3 · Data Analyst
0개 리포트
$108,540
총 연봉
기본급
-
주식
-
보너스
-
$92,259
$124,821
면접 후기
후기 1개
난이도
3.0
/ 5
소요 기간
14-28주
면접 과정
1
Application Review
2
HR Screen
3
Hiring Manager Interview
4
Technical Assessment
5
Panel Interview
6
Offer
자주 나오는 질문
Behavioral/STAR
Technical Knowledge
Past Experience
Culture Fit
최근 소식
Trump cuts drug price deal with Regeneron - Axios
Axios
News
·
1w ago
FDA gives the green light to the first gene therapy for deafness
HN
·
1w ago
·
19
·
1
Regeneron cuts White House pricing deal, offers new gene therapy for free - Pharmaceutical Technology
Pharmaceutical Technology
News
·
1w ago
The FDA gives the green light to the first gene therapy for deafness - NPR
NPR
News
·
2w ago